Identification of CD44+ cancer stem cells in human gastric cancer

Hepato-Gastroenterology

Volumn 60, Issue 124, 2013, Pages 949-954

  Chen, Wenji ^a,b,c   Zhang, Xueping ^c   Chu, Chiyuan ^c   Cheung, Weunghong Leonard ^c   Ng, Lui ^c   Lam, Siaochi ^c   Chow, Ariel ^c   Lau, Tracy ^c   Chen, Minhu ^a   Li, Yuyuan ^b   Nie, Yuqiang ^b   Wong, Ben Chenyu ^c   Pang, Roberta ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cancer stem cell; CD44; Gastric cancer

Indexed keywords

ALDEHYDE DEHYDROGENASE; FLUOROURACIL; HERMES ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STEM CELL; CARCINOGENICITY; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENRICHMENT CULTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPHEROID CELL; STOMACH CANCER;

ANIMALS; ANTIGENS, CD44; ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; FLOW CYTOMETRY; FLUOROURACIL; HUMANS; MICE; MICE, SCID; NEOPLASTIC STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84879584481     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12881     Document Type: Article

References (31)

1. Brenner H, Rothenbacher D, Arndt V: Epidemiology of stomach cancer. Methods Mol Biol 472:467-477, 2009
2. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2008. CA Cancer J Clin 58:71-96, 2008 (Pubitemid 351521864)
3. Yang L, Parkin DM, Ferlay J, Li L, Chen Y: Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14:243-250, 2005 (Pubitemid 40165308)
4. Reya T, Morrison SJ, Clarke MF, Welssman IL: Stem cells, cancer, and cancer stem cells. Nature 414:105-111, 2001 (Pubitemid 33041634)
5. Odoux C, Fohrer H, Hoppo T, et al.: A stochastic model for cancer stem cell origin in metastatic colon cancer. Cancer Res 68:6932-6941, 2008
6. Lobo NA, Shimono Y, Qian D, Clarke MF: The biology of cancer stem cells. Annu Rev Cell Dev Biol 23:675-699, 2007
7. Ma S, Lee TK, Zheng BJ, et al.: CD133+ HCC cancer stem cells confer chemoiesistance by preferential expression of the Akt/PKB survival pathway. Oncogene 27:1749-1758, 2008 (Pubitemid 351380265)
8. Alison MR, Murphy G, Leedham S: Stem cells and cancer: a deadly mix. Cell Tissue Res 331:109-124, 2008 (Pubitemid 350265500)
9. Gokhale PJ, Andrews PW: A prospective on stem cell research. Semin Reprod Med 24:289-297, 2006 (Pubitemid 44877571)
10. Natarajan TG, FitzGerald KT: Markers in normal and cancer stem cells. Cancer Biomark 3:211-231, 2007 (Pubitemid 351492646)
11. Cai J, Cheng A, Luo Y, et al.: Membrane properties of rat embryonic multipotent neural stem cells. J Neurochem 88:212-226, 2004 (Pubitemid 38030224)
12. Ginestier C, Hur MH, Charafe-Jauffret E, et al.: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1:555-567, 2007 (Pubitemid 350056407)
13. Ma S, Chan KW, Lee TK, et al.: Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res 6:1146-1153, 2008
14. Huang EH, Hynes MJ, Zhang T, et al.: Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69:3382-3389, 2009
15. Pearce DJ, Taussig D, Simpson C, et al.: Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples. Stem Cells 23:752-760, 2005 (Pubitemid 40791790)
16. Hess DA, Meyerrose TE, Wirthlin L, et al.: Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 104:1648-1655, 2004 (Pubitemid 39202270)
17. Sophos NA, Vasiliou V: Aldehyde dehydrogenase gene superfamily: the 2002 update. Chem Biol Interact 143-144:5-22, 2003 (Pubitemid 36253575)
18. Magni M, Shammah S, Schiro et al.: Induction of cyclophosphamide- resistance by aldehyde-dehydrogenase gene transfer. Blood 87:1097-1103, 1996 (Pubitemid 26043537)
19. Naor D, Nedvetzki S, Golan I, Melnik L, Faitelson Y: CD44 in cancer. Crit Rev Clin Lab Sci 39:527-579, 2002 (Pubitemid 35425379)
20. Abbaszadegan MR, Moaven O, Sima HR, et al.: p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer. World J Gastroenterol 14:2055-2060, 2008 (Pubitemid 351795826)
21. Zavrides HN, Zizi-Sermpetzoglou A, Panousopoulos D, et al.: Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer. Folia Histochem Cytobiol 43:31-36, 2005 (Pubitemid 40347640)
22. Wang DR, Chen GY, Liu XL, et al.: CD44v6 in peripheral blood and bone marrow of patients with gastric cancer as micro-metastasis. World J Gastroenterol 12:36-42, 2006
23. Ricci-Vitjani L, Lombardi DG, Pilozzi E, et al.: Identification and expansion of human colon-cancer-initiating cells. Nature 445:111-115, 2007 (Pubitemid 46067311)
24. Dean M, Fojo T, Bates S: Tumour stem cells and drug resistance. Nat Rev Cancer 5:275-284, 2005 (Pubitemid 40488633)
25. Yu F, Yao H, Zhu P, et al.: let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131:1109-1123, 2007 (Pubitemid 350235025)
26. Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE: Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One 3:e3077, 2008
27. Dylla SJ, Beviglia L, Park IK, et al.: Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS One 3:e2428, 2008
28. Pang R, Law WL, Chu AC, et al.: A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 6:603-615
29. Takaishi S, Okumura T, Tu S, et al.: Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27:1006-1020, 2009
30. Pietruszko R: Aldehyde dehydrogenase isozymes. Isozymes Curr Top Biol Med Res 8:195-217, 1983
31. Cheung AM, Wan TS, Leung JC, et al.: Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential. Leukemia 21:1423-1430, 2007 (Pubitemid 46965282)